Trimethylammonium

Trimethylammonium

SCHEMBL159696

CN(C)C.[CH2]C

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109935-A1 PROCESS FOR THE PURIFICATION OF MONOCLONAL ANTIBODIES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2024-04-04 US claimed
EP-4291568-A1 PROCESS FOR THE PURIFICATION OF MONOCLONAL ANTIBODIES Council of Scientific & Industrial Research (IN) 2023-12-20 EP claimed
EP-3810742-B1 XYLOSE CARBAMATES AS SOIL RELEASE AGENTS HENKEL AG & CO KGAA (DE) 2022-08-03 EP claimed
CN-114450283-A 3, 6-diamino-pyridazin-3-yl derivatives, pharmaceutical compositions containing them and their use as pro-apoptotic agents 法国施维雅药厂 2022-05-06 CN claimed
CN-114072125-A Hair care compositions comprising an anti-dandruff agent 联合利华知识产权控股有限公司 2022-02-18 CN claimed
EP-3911410-A1 METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES Voyager Therapeutics, Inc. (US) 2021-11-24 EP claimed
US-20210355454-A1 SYSTEMS AND METHODS FOR PRODUCING GENE THERAPY FORMULATIONS VOYAGER THERAPEUTICS, INC. 2021-11-18 US claimed
CN-106749777-B Water soluble hydrophobically associating copolymers 巴斯夫欧洲公司 2021-10-26 CN claimed
CN-113226477-A Hair care compositions comprising pyrithione 联合利华知识产权控股有限公司 2021-08-06 CN claimed
EP-3826719-A1 SYSTEMS AND METHODS FOR PRODUCING GENE THERAPY FORMULATIONS Voyager Therapeutics, Inc. (US) 2021-06-02 EP claimed
WO-2003050184-A1 COSMETIC COMPOSITION COMPRISING A BLOCK COPOLYMER RHODIA CHIMIE (FR) 2003-06-19 WO claimed
WO-2003050195-A2 METHOD FOR DEPOSITING A POLYMER ONTO A SURFACE RHODIA CHIMIE (FR) 2003-06-19 WO claimed
US-6579664-B2 A high performance, photoimageable resin consists of a copolymer of conjugated aliphatic diene, alpha-beta unsaturated carboxylic acid, sulfonic acid, phosphoric acid, amine and ammonium chloride; a polyfunctional acrylate NAPP SYSTEMS, INC. 2003-06-17 US claimed
US-20020172875-A1 High performance, photoimageable resin compositions and printing plates prepared therefrom CITIBANK, N.A. 2002-11-21 US claimed
WO-2002079879-A1 HIGH PERFORMANCE, PHOTOIMAGEABLE RESIN COMPOSITIONS AND PRINTING PLATES PREPARED THEREFROM NAPP SYSTEMS, INC. (US) 2002-10-10 WO claimed
WO-2002068487-A2 USE OF AMPHILIC BLOCK COPOLYMERS IN ORDER TO INCREASE THE WATER AFFINITY OF LOW-ENERGY SURFACES RHODIA CHIMIE (FR) 2002-09-06 WO claimed
WO-1998043962-A1 HETEROCYCLIC INTEGRIN INHIBITOR PRODRUGS DU PONT PHARMACEUTICALS COMPANY (US) 1998-10-08 WO claimed
CN-1034105-C Preparation method of intranasal preparation NOVO INDUSTRI AS (DK) 1997-02-26 CN claimed
WO-1992011001-A1 ORAL PHARMACEUTICAL COMPOSITION SOLVAY (SOCIETE ANONYME) (BE) 1992-07-09 WO claimed
CN-87108340-A Nasal medicine formula and preparation method thereof 1988-07-13 CN claimed